Ignite Creation Date:
2024-05-06 @ 3:36 AM
Last Modification Date:
2024-10-26 @ 11:35 AM
Study NCT ID:
NCT02323100
Status:
TERMINATED
Last Update Posted:
2022-03-21
First Post:
2014-12-18
Brief Title:
Glycerol Phenylbutyrate Corrector Therapy For CF Cystic Fibrosis
Sponsor:
National Jewish Health
Organization:
National Jewish Health
Organization Data
Organization:
National Jewish Health
Class:
OTHER
Study ID:
GPBA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Jewish Health
Lead Sponsor Class:
OTHER
Responsible Party:
Pam Zeitlin
Responsible Party Title:
Professor of Pediatrics
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Jewish Health
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Horizon Pharma Ireland Ltd Dublin Ireland | INDUSTRY |
| University of Alabama at Birmingham | OTHER |
| Childrens Hospital of Philadelphia | OTHER |
| Johns Hopkins University | OTHER |